Từ điển y khoa
Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
RefSeq NM_123605
RNA sequences composed of ADENINE NUCLEOTIDES and URACIL NUCLEOTIDES, that are located in the 3'UNTRANSLATED REGIONS of MESSENGER RNA molecules that are rapidly degraded. They are also known as AREs.
regulates auxin biology and physically interacts with a kinesin-related protein
RefSeq NM_106460
RefSeq NM_124228
a microtubule plus-end binding protein that promotes microtubule reorientation in hypocotyls
RefSeq NM_003600
RefSeq NM_004217
RefSeq NM_003160
amino analog of ibudilast
has antineoplastic activity
inhibits corneal transplant rejection
Gene ID: 554
required for its stability in host cells to modulate plant immunity
a polyclonal antibody, isolated from bovine colostrum, that is specific for human tumor necrosis factor
cytosolic phospholipase A2 inhibitor; structure in first source
cytosolic phospholipase A2 inhibitor; structure in first source
a fluorescent probe; structure in first source
RefSeq NM_178737
structure in first source
a type II transmembrane protein with a Trichome Birefringence-Like domain required for the O-acetylation of xyloglucan
a type II transmembrane protein with a Trichome Birefringence-Like domain required for the O-acetylation of xyloglucan
an SMYD2 inhibitor; structure in first source
inhibitor of prostaglandin E synthase-1; structure in first source
a BACE1 inhibitor; structure in first source
a gamma-secretase modulator; structure in first source
structure in first source
a DYRK1B inhibitor; structure in first source
a gamma-secretase modulator; structure in first source
a PAI-1 inhibitor; structure in first source
a gamma-secretase modulator; structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
TRPV1 antagonist; structure in first source
a glucokinase activator
structure in first source
structure in first source
structure in first source
for imaging of amyloid beta-peptide
in Phase I clinical trial in patients with castrate-resistant prostate cancer (2/2013); structure in first source
a BACE1 inhibitor; structure in first source
for treatment of obesity and diabetes; structure in first source
an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family; structure in first source
a nonfluoroquinolone agent with antimicrobial activity against Staphylococcus aureus